Loading
Instituto Nacional de Oncología y Radiobiología (INOR)
INOR in Havana is Cuba's national cancer hospital and coordinates the national cancer control programme; it is the clinical partner of the Center of Molecular Immunology, whose home-grown lung cancer vaccine CIMAvax-EGF and antibody nimotuzumab were tested in INOR-led trials.
Also called: INOR Havana
Overview
The Instituto Nacional de Oncología y Radiobiología is Cuba's national cancer hospital and research institute, under the Ministry of Public Health, providing surgical oncology, medical oncology, radiotherapy, nuclear medicine and palliative care and coordinating the national cancer control programme. It is the main clinical partner of the Center of Molecular Immunology (CIM), where Cuban biotechnology developed the EGF-targeted lung cancer vaccine CIMAvax-EGF, the anti-EGFR antibody nimotuzumab and other immunotherapies that were tested in INOR-led trials. INOR also trains oncologists for Cuba and partner countries.
Location
Havana, CU
Type
cancer center
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#601 · 4 points (0 Newsweek + 0 NCI + 4 from 2 linked objects) · ranking
Programmes
3- National cancer institute
- Cuban immunotherapy trials (CIMAvax-EGF, nimotuzumab)
- Radiotherapy
People
1Connected
3Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
sld.cu · 1
A source that has moved or gone is reported by the weekly link check. /audit/